Increased mortality in ICU patients ≥70 years old with COVID-19 compared to patients with other pneumonias
Lenneke E M Haas1, Fabian Termorshuizen2,3,4, Corstiaan A den Uil5
1Department of Intensive Care Medicine, Diakonessenhuis, Utrecht, the Netherlands.
Insights
Elderly patients (≥70 years) with COVID-19 admitted to intensive care units (ICUs) have significantly higher mortality rates compared to those with bacterial or viral pneumonia. COVID-19 poses a more severe threat to this age group.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Geriatric Medicine
Background:
- Elderly patients (≥70 years) constitute a significant portion of COVID-19 ICU admissions.
- High mortality rates are observed in this demographic due to COVID-19.
Purpose of the Study:
- To compare outcomes of COVID-19 patients (≥70 years) in Dutch ICUs with similar age groups admitted for bacterial or viral pneumonia.
- To adjust for age, comorbidities, illness severity, and ICU occupancy rates in the comparison.
Main Methods:
- Retrospective cohort study of patients ≥70 years admitted to Dutch ICUs.
- Comparison between COVID-19 patients (March 2020-January 2022) and pneumonia patients (historical and current cohorts).
- Primary outcome measured was hospital mortality.
Main Results:
- 11,525 patients ≥70 years were included: 5094 with COVID-19, 5334 with bacterial pneumonia, 1312 with other viral pneumonia.
- COVID-19 patients (≥70 years) had ICU and hospital mortality rates of 39.7% and 47.6%, respectively.
- Pneumonia patients had significantly lower mortality rates (e.g., 19.5% ICU, 28.6% hospital for bacterial pneumonia historical cohort), even after adjustments.
Conclusions:
- COVID-19 is demonstrably more severe in intensive care unit (ICU) patients aged 70 and older compared to bacterial or viral pneumonia.
- The findings highlight the heightened vulnerability of the elderly to severe COVID-19 outcomes.
Background:
Patients over 70 years old represent a substantial proportion of the COVID-19 ICU population and their mortality rates are high. The aim of this study is to describe the outcomes of patients ≥70 years old admitted to Dutch ICUs with COVID-19, compared to patients ≥70 years old admitted to the ICU for bacterial and other viral pneumonias, with adjustments for age, comorbidities, severity of illness, and ICU occupancy rate.
Methods:
Retrospective cohort study including patients ≥70 years old admitted to Dutch ICUs, comparing patients admitted with COVID-19 from March 1st 2020 to January 1st 2022 with patients ≥70 years old admitted because of a bacterial and other viral pneumonia, both divided in a historical (i.e., January 1st 2017 to January 1st 2020) and current cohort (i.e., March 1st 2020 to January 1st 2022). Primary outcome is hospital mortality.
Results:
11,525 unique patients ≥70 years old admitted to Dutch ICUs were included; 5094 with COVID-19, 5334 with a bacterial pneumonia, and 1312 with another viral pneumonia. ICU-mortality and in-hospital mortality rates of the patients ≥70 years old admitted with COVID-19 were 39.7% and 47.6% respectively. ICU- and hospital mortality rates of the patients who were admitted in the same or in an historical time period with a bacterial pneumonia or other viral pneumonias were considerably lower (19.5% and 28.6% for patients with a bacterial pneumonia in the historical cohort and 19.1% and 28.8% in the same period, for the patients with other viral pneumonias 20.7% and 28.9%, and 22.7% and 31.8% respectively, all p < 0.001). Differences persisted after correction for several clinical characteristics and ICU occupancy rate.
Conclusions:
In ICU-patients ≥70 years old, COVID-19 is more severe compared to bacterial or viral pneumonia.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:


